| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $482.0M | +24.9% | +0.6% |
| Cost of Revenue | $335.0M | +19.2% | +0.9% |
| Gross Profit | $147.0M | +40.0% | +0.0% |
| R&D Expense | $14.0M | +7.7% | +0.0% |
| SG&A Expense | $79.0M | -8.1% | -7.1% |
| Operating Income | $39.0M | +750.0% | -23.5% |
| Pre-tax Income | $20.0M | +233.3% | -48.7% |
| Income Tax | $5.0M | +600.0% | -44.4% |
| Net Income | $16.0M | +233.3% | -48.4% |
| EPS (Basic) | $0.34 | +230.8% | -47.7% |
| EPS (Diluted) | $0.34 | +230.8% | -47.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $343.0M | +12.8% | +104.2% |
| Accounts Receivable | $244.0M | +28.4% | +8.0% |
| Inventory | $506.0M | -10.4% | -6.6% |
| Current Assets | $1.21B | +4.8% | +12.5% |
| Total Assets | $4.50B | -0.4% | -14.0% |
| Current Liabilities | $395.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $31.0M | +121.4% | — |
| Investing Cash Flow | $18.0M | +800.0% | — |
| Financing Cash Flow | -$40.0M | -90.5% | — |
| -14.7% |
| Long-term Debt | $1.37B | -0.9% | +2.8% |
| Stockholders' Equity | $1.87B | -0.6% | -27.1% |